🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Fifteen healthy smokers are given single doses of General Onyx 1 g portion ...
Status
Completed
Location
Carema AB
Start Date
2006-03
Trial ID
NCT01182129
The study aims to establish if a low-nitrosamine, smokeless tobacco product...
Status
Completed
Location
Institute of Nuclear Sciences "Vinca"
Start Date
2008-01
Trial ID
NCT00601042
Treatments Being Tested
In an open label, randomized, two-way cross-over study, 32 male healthy reg...
Status
Completed
Location
CROel AB
Start Date
2004-05
Trial ID
NCT01249339
This is an observational study of pooled population-based samples in three ...
Status
Completed
Location
Karolinska Institutet
Start Date
2022-04-01
Trial ID
NCT05321433
The purpose of this study is to compare plasma nicotine uptake in adult snu...
Status
Completed
Location
Woodland Research Northwest, LLC
Start Date
2019-07-08
Trial ID
NCT03993782
The current study proposes to investigate the effects of chronic snus use o...
Status
Completed
Location
Dept of Medicine, Lung and Allergy section, University Hospital
Start Date
2015-09
Trial ID
NCT02564289
In an open label, randomized, two-way cross-over study, 32 male healthy reg...
Status
Completed
Location
CROel AB
Start Date
2004-05
Trial ID
NCT01369693
Treatments Being Tested
This study seeks to measure the effects of smokeless tobacco product risk m...
Status
Recruiting
Location
Roswell Park
Start Date
2026-05-11
Trial ID
NCT07107139
Treatments Being Tested
With the advent of restrictions on public smoking, the tobacco industry has...
Status
Withdrawn
Location
Tobacco Research Center
Start Date
2010-03
Trial ID
NCT01100216
Treatments Being Tested
This is an observational study of participants in three general population ...
Status
Completed
Location
Finland
Start Date
2017-10-02
Trial ID
NCT04915781
Treatments Being Tested